Clinical trial
Real-world Observational Study of Guselkumab Persistence in Patients With Crohn's Disease and Ulcerative Colitis
NCT07746765 is registered in ClinicalTrials.gov with Janssen Sciences Ireland UC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Real-world Observational Study of Guselkumab Persistence in Patients With Crohn's Disease and Ulcerative Colitis
- Lead sponsor
- Janssen Sciences Ireland UC
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- October 30, 2026
- Completion date
- October 30, 2029
- Enrollment
- 35 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.